Wellbeing Digital Sciences (NEO:MEDI.AQN, OTCQB:KONEF) CEO Najla Guthrie joined Steve Darling from Proactive to share news Health Canada has awarded the company’s subsidiary KGK Science a Cannabis Research License. Guthrie telling Proactive this license is for its new state-of-the-art facility thus allowing the Company to keep cannabis for the purpose of research and development. This designation will also allow KGK to reduce timelines not having to always get approval per project. Guthrie also shared with Proactive that KGK has, through a clinical study, shown positive results of UP446 supplementation in helping mount a robust immune response following influenza vaccination.
Wellbeing Digital Sciences announces company has received Cannabis License from Health Canada
